NEW YORK (GenomeWeb) – A team of researchers led by SomaLogic's Larry Gold has found nearly four dozen proteins whose levels vary in the serum of patients with Duchenne muscular dystrophy as compared to people without the disorder.

As they reported in a paper to appear in the Proceedings of the National Academy of Sciences this week, the serum levels of these 44 proteins were significantly different in patients from two different independent cohorts. Some of these differences, the researchers noted, were age-dependent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.